崅抦戝妛堛妛晹晬懏昦堾 栻嵻晹

Kato H, Umemura T, Hagihara M, Shiota A, Asai N, Hamada Y, Mikamo H, Iwamoto T. Development of a therapeutic drug-monitoring algorithm for outpatients receiving voriconazole: A multicentre retrospective study. Br J Clin Pharmacol. 2024, 90(5):1222-1230.

Ishigo T, Matsumoto K, Yoshida H, Tanaka H, Ibe Y, Fujii S, Fukudo M, Fujihara H, Yamaguchi F, Ebihara F, Maruyama T, Hamada Y, Samura M, Nagumoi F, Komatsu T, Tomizawa A, Takuma A, Chiba H, Nishi Y, Enoki Y, Taguchi K, Suzuki A. Relationship between nephrotoxicity and area under the concentration-time curve of vancomycin in critically ill patients: a multicenter retrospective study. Microbiol Spectr. 2024, 12(7):e0373923.

Kato H, Hamada Y, Takano S, Ikeda S, Seto Y, Matsushita K, Yamada K, Uchiyama K. A systematic review and meta-analysis of antibiotic-loaded bone cement for prevention of deep surgical site infections following primary total joint replacement. J Infect Chemother. 2024, 30(9):904-911.

Ishigo T, Fujii S, Ibe Y, Aigami T, Nakano K, Fukudo M, Yoshida H, Tanaka H, Ebihara F, Maruyama T, Hamada Y, Suzuki A, Fujihara H, Yamaguchi F, Samura M, Nagumo F, Komatsu T, Tomizawa A, Takuma A, Chiba H, Nishi Y, Enoki Y, Taguchi K, Matsumoto K. Flowchart for predicting achieving the target area under the concentration-time curve of vancomycin in critically ill Japanese patients: A multicenter retrospective study. J Infect Chemother. 2024, 30(4):329-336.

Umemura T, Kakizaki H, Mutoh Y, Mizuno T, Ito Y, Hioki T, Kato H, Hagihara M, Yamada T, Ikeda Y, Mikamo H, Ichihara T, Hamada Y. Effectiveness and safety of the simulation-based first-dose design of voriconazole. J Infect Chemother. 2024, S1341-321X(24)00170-3.

Hamada Y, Yagi Y. Therapeutic drug monitoring of azole antifungal agents. J Infect Chemother. 2024, S1341-321X(24)00276-9.

Kawada K, Ishida T, Morisawa S, Jobu K, Higashi Y, Aizawa F, Yagi K, Ishizawa Y, Niimura T, Abe S, Goda M, Miyamura M, Ishizawa K, Atractylodes lancea (Thunb.) DC. [Asteraceae] rhizome-derived exosome-like nanoparticles suppress lipopolysaccharide-induced inflammation in murine microglial cells, Front Pharmacol. 2024 ,15, 1302055

Endo A, Hanawa K, Asakawa D, Ishibe T, Nakane Y, Matsumoto K, Hamada Y. Potential risk factors for early acute kidney injury in patients treated with vancomycin. J Infect Chemother. 2024, 30(10):989-994.

Yagi Y, Yanagisawa N, Higuchi S, Okazaki M, Kawada K, Ishida T, Jobu K, Arakawa Y, Kadota T, Kawanishi Y, Fukuda H, Ueba T, Yamagishi Y, Hamada Y. Outcome evaluation of pharmacist-physician collaborative protocol-based antimicrobial treatment for hospitalized stroke patients with aspiration pneumonia. J Infect Chemother. 2024, S1341-321X(24)00269-1.

Yusuke Yagi, Akito Doke, Saya Iwame, Yu Arakawa, Yuka Yamagishi. Epidemiological Study on Case Definition of Methicillin-Resistant Staphylococcus aureus Enteritis, Infection and Drug Resistance 17: 2237-2247, 2024.

Yu Arakawa, Yusuke Yagi, Airi Mimoto, Yoshie Nishida, Shunsuke Kuwana, Eiichi Nakai, Tetsuya Ueba, Mikiya Fujieda, Yuka Yamagishi. Management of a Large Cerebral Abscess in Children Caused by Campylobacter gracilis: A Case Report and Review of the Literature, Cureus 16(6): e62744.

Yusuke Yagi, Yuka Yamagishi, Yukihiro Hamada. Optimized Antifungal Therapy for Chronic Pulmonary Aspergillosis, Medical Mycology Journal 65(3):59-65, 2024.